Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-24 | 2024-12-24 | 2024-12-24 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $388.5M | $491.4M | -- | -- | -- | |
| Total Assets | $6.8B | $6.9B | -- | -- | -- | |
| Current Liabilities | $201.9M | $218.6M | -- | -- | -- | |
| Total Liabilities | $4.7B | $4.8B | -- | -- | -- | |
| Total Equity | $2.1B | $2.1B | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-24 | 2024-12-24 | 2024-12-24 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
Ryman Healthcare Ltd. engages in the development and management of integrated retirement villages for the elderly. The firm offers services, apartments, rest homes, hospitals, and provides dementia and short-term care. It operates through the following geographical segments: New Zealand and Australia. The company was founded by John William Dudley Ryder and Kevin James Hickman in 1984 and is headquartered in Christchurch, New Zealand.
In the current month, RYHTY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RYHTY average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that Ryman Healthcare Ltd. share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about Ryman Healthcare Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ryman Healthcare Ltd. is a Sell and believe this share price will rise from its current level to --.
The price target for Ryman Healthcare Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Ryman Healthcare Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of Ryman Healthcare Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ryman Healthcare Ltd. shares.
Ryman Healthcare Ltd. was last trading at $8.31 per share. This represents the most recent stock quote for Ryman Healthcare Ltd.. Yesterday, Ryman Healthcare Ltd. closed at $8.31 per share.
In order to purchase Ryman Healthcare Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
UniFirst Corp. [UNF] is up 0.77% over the past day.